This substance was identified for action under the Chemicals Management Plan (CMP).
|CAS RN||Common name||DSL name||Draft screening assessment||Proposed conclusion on section 64 criteria||Follow-up activities|
|105-60-2||Caprolactam||2H-Azepin-2-one, hexahydro-||HTML||Does not meet||None planned at this time|
|August 2022||Anticipated publication of the final screening assessment.|
|August 14, 2021||Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 33.|
Report a problem or mistake on this page
- Date modified: